Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
Warfarin is commonly used in thromboembolic conditions. Warfarin interruption represents a significant challenge in pre-operative warfarin management as it is associated with major consequences. Genetics polymorphism demonstrated to be a significant predictor of the required days of warfarin interru...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | article |
| Published: |
2022
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1016/j.cpcardiol.2022.101128 https://www.sciencedirect.com/science/article/pii/S0146280622000263 http://hdl.handle.net/10576/41415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|